Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AZITHROMYCIN for Dermatitis: Side Effects & Safety Data

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

There are 5 adverse event reports in the FDA FAERS database where AZITHROMYCIN was used for Dermatitis.

Most Reported Side Effects for AZITHROMYCIN

Side Effect Reports % Deaths Hosp.
Off label use 2,979 17.0% 316 1,334
Drug ineffective 2,609 14.9% 316 1,131
Drug hypersensitivity 1,978 11.3% 16 199
Dyspnoea 1,409 8.0% 125 816
Condition aggravated 1,063 6.1% 186 545
Nausea 1,006 5.7% 20 493
Asthma 972 5.5% 65 653
Wheezing 951 5.4% 62 622
Product use in unapproved indication 886 5.1% 70 246
Cough 837 4.8% 32 433
Diarrhoea 828 4.7% 33 282
Therapeutic product effect incomplete 772 4.4% 65 523
Pyrexia 689 3.9% 23 483
Headache 668 3.8% 10 352
Drug ineffective for unapproved indication 637 3.6% 147 277

Other Indications for AZITHROMYCIN

Product used for unknown indication (3,423) Covid-19 (1,272) Pneumonia (1,003) Mycobacterium avium complex infection (711) Antibiotic therapy (519) Covid-19 pneumonia (408) Bronchitis (370) Infection (261) Sinusitis (245) Mycobacterium abscessus infection (239)

Other Drugs Used for Dermatitis

DUPILUMAB (9,959) CRISABOROLE (407) APREMILAST (122) TRALOKINUMAB-LDRM (90) KETOCONAZOLE (66) CYCLOSPORINE (62) DOXYCYCLINE (57) PIMECROLIMUS (55) CLOBETASOL (50) RUXOLITINIB (50)

Related Pages

AZITHROMYCIN Full Profile All Dermatitis Drugs AZITHROMYCIN Demographics AZITHROMYCIN Timeline